EuroGRAFT

cGvHD
Action Outputs

The main aim and objective of the Action is to establish a European Network to further understand chronic GvHD, through networking and interdisciplinary training.

Frontiers Research Topic- Managing GvHD in the Era of Personalized Medicine

	Managing Chronic GvHD in the Era of Personalized Medicine
	Direct Link to papers published in the research topic

Publications

	Profiling Tissue and Biofluid miR-155-5p, miR-155*, and miR-146a-5p Expression in Graft vs. Host Disease
	Evaluation of the Cost of Survivorship Care After Allogeneic Hematopoeitic Stem Cell Transplantation-An Analysis of 2 German Transplantation Centers. Frontiers in Public Health.
	Review of Genetic Variation as a Predictive Biomarker for Chronic Graft-Versus-Host-Disease After Allogeneic Stem Cell Transplantation. Frontiers in Immunology.
	New Approaches for the Treatment of Chronic Graft-Versus-Host Disease: Current Status and Future Directions. Frontiers in Immunology.
	Neutrophils cause a "NET" increase in skin allograft allogenicity Brouard S, Mooney N. Am J Transplant. 2019 Dec 17. doi: 10.1111/ajt.15746. [Epub ahead of print]
	A Systematic Review of Patient Reported Outcome Measures in Graft-versus-Host-Disease (GVHD) Kilgour DJ, Wali DG, Gibbons ME, Scherwath DA, Badiella DAB, Peniket DA, Schoemans DH, Matin DRN. Biol Blood Marrow Transplant. 2020 Feb 3. pii: S1083-8791(20)30055-0. doi: 10.1016/j.bbmt.2020.01.022. [Epub ahead of print]

Poster Presentations

	1. European Society for Blood and Marrow Transplantation 46th annual meeting 2020, Madrid, Spain Incidence of chronic Graft-versus-Host Disease – results from a prospective multicentre analysis of 2 cohorts. A. Lelas, R. Langer, M. Rittenschober, L. Desnica, H.Greinix, A. Dickinson, M. Inngjerdingen, A. Lawitschka, R.Vrhovac, D. Pulanic, S. Klein, J.M. Middeke, M. Edinger, D. Wolff
	2. European Society for Blood and Marrow Transplantation 46th annual meeting 2020, Madrid, Spain Practice patterns in chronic GVHD patient management and patient reported outcome measures across the EBMT Allogenic Transplantation Network. Ivan Sabol, Vladimir Perovic, Magdalena Grce, Marit Inngjerdingen, Drazen Pulanic, Christophe Peczynski, Emmanuelle Polge, Zinaida Peric, Christian Koenecke, Anne Dickinson, Hildegard Greinix, Grzegorz Basak, Olaf Penack, Angela Scherwath, Anna Barata, Attilio Olivieri, Anita Lawitschka, Patrycja Mensah-Glanowska, Hajnalka Andrikovics, Miklos Laszlo Udvardy, Helene Schoemans, Daniel Wolff

Oral Presentations

	1. The 34th European Immunogenetics and Histocompatibility Conference annual meeting 2020, Glasgow, UK Differential expression of miRNAs in chronic Graft-versus-Host Disease. K. Bogunia-Kubik, P. Lacina1, R. E. Crossland, J. Wielińska, A. Czyż, M. Ussowicz, T. Wróbel, A. Dickinson

See Also

Find out more about the Action by exploring the site links on the right hand side.

Aims & Objectives

How to Participate

Resources

News & events

Are you interested
in taking part?

The COST Action EUROGRAFT welcomes research-active scientists working in the field. There are many ways to get involved.

Get involved

Do you have a question?

If you have any questions or would like to know more about the project, simply connect with us and we’ll be happy to talk to you.

Connect with us